Background

Forte Medical has introduced precision and reduced costs attached to routine and specialist urinary diagnostics.

Urine has diagnostic parity with blood, yet there is no protocol for its reliable and hygienic collection, essential when accuracy is important.

Having launched Peezy Midstream to transform the accuracy, hygiene and dignity attached to women’s UTI and antenatal health screening, Forte Medical is now working on important new urine collection systems to satisfy diagnostic and screening standards for early stage cancers, sports dope testing and evidential forensic medicine.

Watch this short film from Dr Vincent Forte on why he invented Peezy Midstream.

Buy Peezy Midstream from the NHS Supply Chain Catalogue.

The Journey

In 2002, Dr. Vincent Forte, a Medical Author and British NHS Primary Care and Forensic Physician

noted that diagnosis and treatment for women’s Urinary Tract infection (UTI) was unreliable, undignified and unhygienic, leading to repeat appointments, repeat laboratory tests and unnecessary prescribing. His invention tackles incumbent failures to address right-first-time practice.

He responded to his patient’s concerns and to failed diagnosic outcomes by conceiving Peezy Midstream. After winning the inaugural Medical Futures Innovation Award, he invited his sister Giovanna Forte a business consultant to lead product and company development, while he remained a full-time NHS Primary Care and Forensic Physician. Retired from the NHS, Vincent is now Medical Director at Forte Medical Limited.

Evidence-based Peezy Midstream is proven to reduce specimen contamination to as low as 0% in GP surgery, with up to 66% savings on lab costs. It is now avaiable on the NHS Supply Chain Catalogue.

Peezy Midstream stops healthcare budgets being flushed away and protects women from unnecessary antibiotics

Between 34% – 60% of women presenting with UTI are prescribed antibiotics before diagnosis is confirmed. The practice of empirical antibiotic treatment across the world not only puts women on the frontline of Antimicrobial Resistance (AMR), but can impact pregnancy and exacerbate cognitive issues in the elderly, risking preventable hospitalisation.